Primary prevention of sudden cardiac death using implantable cardioverter defibrillators

Area of Science:

• Cardiology
• Medical Devices
• Public Health

Background:

• Sudden cardiac death (SCD) persists as a leading cause of mortality in industrialized nations.
• Despite advances, effective primary prevention strategies for SCD remain critical.

Purpose of the Study:

• To review progress in risk stratification for identifying patients at high risk of SCD.
• To evaluate clinical trials on primary prevention of SCD using implantable cardioverter defibrillators (ICDs).
• To analyze the efficacy and cost-effectiveness of ICDs, including their combined use with cardiac resynchronization therapy (CRT).

Main Methods:

• Literature review of clinical trials and risk stratification methods for SCD.
• Analysis of data on the efficacy of implantable cardioverter defibrillators (ICDs).
• Evaluation of studies on combined cardiac resynchronization therapy (CRT) and ICD use.
• Cost-effectiveness analysis of ICD implantation.

Main Results:

• Implantable cardioverter defibrillators (ICDs) are effective for primary prevention of SCD in selected high-risk patients.
• Combined use of cardiac resynchronization therapy (CRT) with ICDs shows efficacy in specific patient groups.
• Risk stratification tools are evolving to better identify candidates for ICD therapy.

Conclusions:

• Implantable cardioverter defibrillators (ICDs) represent a key strategy for primary prevention of sudden cardiac death (SCD) in high-risk populations.
• Further research and refined risk stratification are needed to optimize ICD use and cost-effectiveness.
• The combined therapy of cardiac resynchronization therapy (CRT) with ICDs offers benefits for specific patient profiles.